Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran)

Medical Science Monitor

Volumn 8, Issue 12, 2002, Pages

  Mansour Ghanaei, Fariborz ^a,c   Fallah, Mohammad Sadegh ^a   Shafaghi, Afshin ^a   Yousefi Mashhoor, Mahmood ^a   Ramezani, Naghi ^a   Farzaneh, Farshid ^a   Nassiri, Reza ^b  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alanine aminotransferase; HCV antibody; Hemophilia; Hepatitis B surface antigen; Iran

Indexed keywords

ALANINE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9 CONCENTRATE; FRESH FROZEN PLASMA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; HEMOPHILIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IRAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; VACCINATION;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; CHILD; CHILD, PRESCHOOL; FACTOR IX; FACTOR VIII; FEMALE; HEMOPHILIA A; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IRAN; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PLASMA; SEROEPIDEMIOLOGIC STUDIES;

EID: 0036961992     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fauci AS, Braunwald E, Isselbacber K et al: Harrison's Principles of Internal Medicine. 14th edition. MC-Graw Hill. 1998; 736-8
2. hite GC, Zeitler KD, Lesensne HR et al: Chronic hepatitis in patients with hemophilia A: Histologic studies in patients with intermittently abnormal liver function tests. Blood, 1982; 60(6): 1259-62
3. Aledort LM, Levine PH, Hilgartner M et al: A Study of Liver biopsies and liver disease among hemophiliacs. Blood, 1985; 66(2): 367-72
4. Darby SC, Ewart DW, Giangrande PL et al: Mortality from liver cancer and liver disease in hemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Hemophilic center Director's Organization. Lancet, 1997; 350(9089): 1425-31
5. Yaghobi M: Seroepidemiology of HC V in hemophilia and thalasemia. Zendegi (Iran Hemophilia Society Qnarterly), 1997; 3(6): 48
6. Aghazadeh M, Amini S, Mahmoodi M: Prevalence of HBV in members of HbsAg carriers' family in Eastern Arbayejan and Ardabil. Zendegi (Iran Hemophilia Society Quarterly), 1997; 3(6): 49
7. Ghamari M, Hashemieh M: Hepatitis C in hemophilia and thalasemia major in Markazi province. Zendegi (Iran Hemophilia Society Quarterly), 1998; 3(9,10): 63
8. Zendeg/(Iran Hemophilia Society Quarterly): Editorial, 1997; 3(6): 2-3
9. Adamowicz-Salach A, Pawelec K, Loch T et al: Incidence and treatment of hepatitis C Virus infection in children with hemophilia in Poland. Hemophilia, 1999; 5(6): 436-40
10. Benjelloum S, Bahbouhi B, Sekkat S et al: Anti - HCV Seroprevalence and risk factor of heoatitis C virus infection in Moroccan Population groups. Res virol, 1996; 147(4): 247-55
11. Fukuda Y, Nakano I, Katano Y et al: Assessment and treatment of liver diseases in Japanese Hemophilia patients. Hemophilia, 1998; 4(4): 595-600
12. Tradati F, Colomba M, Manauci PM et al: A prospective multicenter hemophiliacs with chronic hepatitis C. Blood, 1998; 91(4): 1173-7
13. Ryder SD, Beckingham IJ: Acute hepatitis. BMJ, 2001; 322: 151-3
14. Ruggiero G, Cesaro G, Mazzella C et al: Liver disease in hemophiliacs: etiological and biochemical data on 159 cases from our geographical area. Hepatogastroenterology, 1985; 32(2): 57-60
15. Kim Hc, Saidi P, Ackley AM et al: Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease. Gastroenterology, 1980; 79(6): 1159-64
16. Hasiba U, Eyster ME, Gill FM et al: Liver dysfunction in pennsylvania's multitransfused hemophiliacs. Dig Dis Sci, 1980; 25(10): 776-82
17. Ng HW: Liver dysfunction in hemophilia A, B and other hereditary haemorrhagic disorders. Ann Acad Med Singapore, 1984; 13(3): 524-6
18. Cederbaum AI, Blatt PM, Levine pH: Abnormal Serum transaminase levels in patients with hemophilia A. Arch Intern Med, 1982; 142(3): 481-4
19. Mc Verry Ba, Voke J, Mohammed I et al: Immune complexes and abnormal liver function in hemophilia. J Clin pathol, 1997; 30(12): 1142-6
20. Gomperts ED, Lazerson J, sergis-Deavenport E: Hepatocellular enzyme patterns and hepatits B virus exposure in multitransfused young and very young hemophilia patients. Am J Hematol, 1981; 11(1): 55-9
21. Preston FE, Triger DR, Underwood JC et ah Percutaneous liver biopsy and chronic liver disease in hemophiliacs. Lancet, 1978; 2(8090): 592-4
22. Schulman S, Wiechel B: Hepatitia, epidemiology and Liver function in hemophiliacs in Sweden, Acta Med Scand, 1984; 215(3): 249-56
23. Card RT, Dusevic M, Lukie BE: Coagulation Factor therapy for hemophilia: relation to hepatitis B and to liver function. Can Med Assoc J, 1982; 126(1): 34-6